Grifols SA (GIKLY) stock
GIKLYOTCPharmaceutical PreparationsAlso trades as GIFLF, GIFOF, GRFS
$5.55+0.00 (0.00%)
Close on Oct 19, 2026Market cap $1.91BP/E 4.2Yield –
Grifols cash
Cash and short-term investments held at the end of each period.
Grifols's cash was €825.00M at Dec 31, 2025. For fiscal 2025 it was €825.00M, down 15.8% from the year before. Over ten years it grew -3.2% a year on average. The highest annual figure on record is €2.68B in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €825.00M | -15.8% |
| FY2024 | Dec 31, 2024 | €980.00M | +85.3% |
| FY2023 | Dec 31, 2023 | €529.00M | -3.6% |
| FY2022 | Dec 31, 2022 | €549.00M | -79.5% |
| FY2021 | Dec 31, 2021 | €2.68B | +361.7% |
| FY2020 | Dec 31, 2020 | €579.65M | -21.9% |
| FY2019 | Dec 31, 2019 | €741.98M | -28.2% |
| FY2018 | Dec 31, 2018 | €1.03B | +16.6% |
| FY2017 | Dec 31, 2017 | €886.52M | -0.9% |
| FY2016 | Dec 31, 2016 | €895.01M | -21.7% |
| FY2015 | Dec 31, 2015 | €1.14B | +5.9% |
| FY2014 | Dec 31, 2014 | €1.08B | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | €825.00M | -69.2% |
| Q4 FY2024 | Dec 31, 2024 | €980.00M | +69.1% |
| Q4 FY2023 | Dec 31, 2023 | €529.00M | -28.7% |
| Q4 FY2022 | Dec 31, 2022 | €549.00M | -46.9% |
| Q4 FY2021 | Dec 31, 2021 | €2.68B | +201.9% |
| Q4 FY2020 | Dec 31, 2020 | €579.65M | -35.2% |
| Q4 FY2019 | Dec 31, 2019 | €741.98M | -35.1% |
| Q4 FY2018 | Dec 31, 2018 | €1.03B | -4.2% |
| Q4 FY2017 | Dec 31, 2017 | €886.52M | – |
| Q4 FY2016 | Dec 31, 2016 | €895.01M | – |
| Q4 FY2015 | Dec 31, 2015 | €1.14B | – |
| Q4 FY2014 | Dec 31, 2014 | €1.08B | – |
See a number that looks wrong?